A Double-Blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia

Archives of General Psychiatry
doi 10.1001/archpsyc.59.5.441